Epidemiology of virus infection and human cancer

Recent Results in Cancer Research

Volumn 193, Issue , 2014, Pages 11-32

  Chen, Chien Jen ^a,b   Hsu, Wan Lun ^b   Yang, Hwai I ^c   Lee, Mei Hsuan ^d   Chen, Hui Chi ^a   Chien, Yin Chu ^c   You, San Lin ^a  

^a GENOMICS RESEARCH CENTER   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Cancer; EBV; Epidemiology; HBV; HCV; HIV; HPV; HTLV I; KSHV

Indexed keywords

ANTIVIRUS AGENT; VIRUS VACCINE;

ANTIVIRAL THERAPY; ANUS CANCER; ARTICLE; BURKITT LYMPHOMA; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CARCINOGENESIS; CAUSAL ATTRIBUTION; DISEASE TRANSMISSION; EPSTEIN BARR VIRUS INFECTION; HEPATITIS B; HEPATITIS C; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFECTION RATE; INFECTION RISK; KAPOSI SARCOMA; LIVER CELL CARCINOMA; MALIGNANT NEOPLASTIC DISEASE; MOUTH CANCER; NASOPHARYNX CARCINOMA; OROPHARYNX CANCER; PAPILLOMAVIRUS INFECTION; PENIS CANCER; PRIORITY JOURNAL; RISK ASSESSMENT; T CELL LEUKEMIA; TONSIL CANCER; TUMOR VIRUS; UTERINE CERVIX CANCER; VACCINATION; VIRUS INFECTION; VULVA CANCER; CLINICAL TRIAL (TOPIC); DISEASE ASSOCIATION; DRUG EFFICACY; EPSTEIN BARR VIRUS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HERPES VIRUS INFECTION; HERPESVIRIDAE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 1 INFECTION; INCIDENCE; INFECTION CONTROL; NEOPLASM; NONHUMAN; PREVALENCE; UTERINE CERVIX CARCINOMA; VIRUS LOAD; WART VIRUS;

HUMANS; NEOPLASMS; ONCOGENIC VIRUSES; TUMOR VIRUS INFECTIONS;

EID: 84958255113     PISSN: 00800015     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-38965-8_2     Document Type: Article

References (55)

1. Alter MJ (2007) Epidemiology of hepatitis C virus infection. World J Gastroenterol 13:2436-24411
2. Chang MH, Chen CJ, Lai MS, Kong MS, Wu TC, Liang DC, Hsu HM, Shau WY, Chen DS (1997) Taiwan Childhood Hepatoma Study Group. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. New Engl J Med 336:1855-18599
3. Chang MH, You SL, Chen CJ, Liu CJ, Lee CM, Lin SM, Chu HC, Wu TC, Yang SS, Kuo HS, Chen DS (2009) The Taiwan hepatoma study group. decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. J Natl Cancer Inst 101:1348-13555
4. Chang YJ, Chen HC, Lee BH, You SL, Lin CY, Pan MH, Chou YC, Hsieh CY, Chen YM, Chen YJ, Chen CJ (2011) Unique variants of human papillomavirus genotypes 52 and 58 and risk of cervical neoplasia. Int J Cancer 129:965-9733
5. Chen CJ (2005) Time-dependent events in natural history of occult hepatitis B virus infection: Importance of population-based long-term follow-up study with repeated measurements (Editorial). J Hepatology 42:438-4400
6. Chen CJ, Chen DS (2002) Interaction of hepatitis B virus, chemical carcinogen and genetic susceptibility: multistage hepatocarcinogenesis with multifactorial etiology (editorial). Hepatology 36:1046-10499
7. Chen CJ, Lee MH (2011) Early diagnosis of hepatocellular carcinoma by multiple microRNAs: validity, efficacy and cost-effectiveness (editorial). J Clin Oncol 29:4745-47477
8. Chen CJ, Yang HI (2011) Natural history of chronic hepatitis B REVEALed. J Gastroenterol Hepatol 26:628-6388
9. Chen CJ, Liang KY, Chang AS, Chang YC, Lu SN, Liaw YF, Chang WY, Sheen MC, Lin TM (1991) Effects of hepatitis B virus, alcohol drinking, cigarette smoking and familial tendency on hepatocellular carcinoma. Hepatology 13:398-4066
10. Chen CJ, Yu MW, Liaw YF, Wang LW, Chiamprasert S, Matin F, Hirvonen A, Bell AB, Santella RM (1996a) Chronic hepatitis B carriers with null genotypes of glutathione S-transferase M11 and T1 polymorphisms who are exposed to aflatoxins are at increased risk of hepatocellular carcinoma. Am J Hum Genet, 59:128-1344
11. Chen CJ, Wang LY, Lu SN, Wu MH, You SL, Li HP, Zhang YJ, Wang LW, Santella RM (1996b) Elevated aflatoxin exposure and increased risk of hepatocellular carcinoma. Hepatology 24:38-422
12. Chen CJ, Yu MW, Liaw YF (1997) Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroen Hepatol 12:S294-S3088
13. Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, Huang GT, Iloeje UH (2006) Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006(295):65-733
14. Chen CL, Yang HI, Yang WS, Liu CJ, Chen PJ, You SL, Wang LY, Sun CA, Lu SN, Chen DS, Chen CJ (2008) Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/ C virus infection: a follow-up study in Taiwan. Gastroenterology 135:111-1211
15. Chen CJ, Yang HI, Iloeje UH (2009) REVEAL-HBV Study Group. Hepatitis B virus DNA levels and outcomes in chronic hepatitis B. Hepatology 49:S72-S844
16. Chen CF, Lee WC, Yang HI, Chang HC, Jen CL, Iloeje UH, Su J, Hsiao KC, Wang LY, You SL, Lu SN, Chen CJ (2011a) Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma risk. Gastroenterology 141:1240-12488
17. Chen HC, You SL, Hsieh CY, Lin CY, Pan MH, Chou YC, Liaw KL, Schiffman M, Hsing AW, Chen CJ (2011b) For CBCSP-HPV Study Group. Prevalence of genotype- specific human papillomavirus infection and cervical neoplasia in Taiwan: a community-based survey of 10,602 women. Int J Cancer 128:1192-12033
18. Chen HC, Schiffman M, Lin CY, Pan MH, You SL, Chuang LC, Hsieh CY, Liaw KL, Hsing AW, Chen CJ (2011c) CBCSP-HPV study group. persistence of type-specific human papillomavirus infection and increased long-term risk of cervical cancer. J Natl Cancer Inst 103:1387-13966
19. Chien YC, Chen CJ (2003) Epidemiology and etiology of nasopharyngeal carcinoma: geneenvironment interaction. Cancer Rev Asia-Pacific 1:1-199
20. Chien YC, Chen JY, Liu MY, Yang HI, Hsu MM, Chen CJ, Yang CS (2001) Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. New Engl J Med 345:1877-18822
21. Chien YC, Jan CF, Kuo HS, Chen CJ (2006) Nationwide hepatitis B vaccination program in Taiwan: Effectiveness in 20 years after it was launched. Epidemiol Rev 28:126-1355
22. Cho EY, Hildesheim A, Chen CJ, Hsu MM, Chen IH, Mittl BF, Levine PH., Liu MY, Chen JY, Brinton LA, Cheng YJ, Yang CS (2003) Nasopharyngeal carcinoma and genetic polymorphisms of DNA repair enzymes XRCC1 and hOGG1. Cancer Epidemiol Biomarker Prev, 12:1100-11044
23. Chuang LC, Hu CY, Chen HC, Lin PJ, Lee B, Lin CY, Pan MH, Chou YC, You SL, Hsieh CY, Chen CJ (2012) Associations of human leukocyte antigen class II genotypes with human papillomavirus 18 infection and cervical intraepithelial neoplasia risk. Cancer 118:223-2311
24. de Sanjose S, Diaz M, Castellsague X, Clifford G, Bruni L, Munoz N, Bosch FX (2007) Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 7:453-4599
25. Dukers NH, Rezza G (2003) Human herpesvirus 8 epidemiology: what we do and do not know. AIDS 17:1717-17300
26. Hildesheim A, Anderson LM, Chen CJ, Cheng YJ, Brinton LA, Daly AK, Reed CD, Chen IH, Caporaso NE, Hsu MM, Chen JY, Idle JR, Hoover RN, Yang CS, Chabra SK (1997) CYP2E11 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst 89:1207-12122
27. Hildesheim A, Dosemeci M, Chan CC, Chen CJ, Cheng YC, Hsu MM, Chen IH, Mittl BF, Sun B, Levine PH, Chen JY, Brinton LA, Yang CS (2001) Occupational exposure to wood, formaldehyde, and solvents and risk of nasopharyngeal carcinoma. Cancer Epidemiol Biomarker Prev 2001(10):1145-11533
28. Hildesheim A, Apple RJ, Chen CJ, Wang SS, Cheng YC, Klitz W, Mack SJ, Chen IH, Hsu MM, Yang CS, Brinton LA, Levine PH, Erlich HA (2002) Association of HLA class I and II alleles and extended haplotypes with nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst 94:1780-17899
29. Hsu WL, Chen JY, Chien YC, Liu MY, You SL, Hsu MM, Yang CS, Chen CJ (2009) Independent effects of EBV and cigarette smoking on nasopharyngeal carcinoma: a 20-year follow-up study on 9,622 males without family history in Taiwan. Cancer Epidemiol Biomarkers Prev 18:1218-12266
30. Hsu WL, Yu KJ, Chien YC, Chiang JY, Cheng YJ, Chen JY, Liu MY, Chou SP, You SL, Hsu MM, Lou PJ, Wang CP, Hong JH, Leu YS, Tsai MH, Su MC, Tsai ST, Chao WY, Ger LP, Chen PR, Yang CS, Hildesheim A, Diehl SR, Chen CJ (2011) Familial tendency and risk of nasopharyngeal carcinoma in Taiwan: effects of covariates on risk. Am J Epidemiol 173:292-2999
31. Hsu WL, Pan WH, Chien YC, Yu KJ, Cheng YJ, Chen JY, Liu MY, Hsu MM, Lou PJ, Chen IH, Yang CS, Hildesheim A, Chen CJ (2012a) Lowered risk of nasopharyngeal carcinoma and intake of plant vitamin, fresh fish, green tea and coffee: a case-control study in Taiwan. PLoS ONE 7:e417799
32. Hsu WL, Tse KP, Liang S, Chien YC, Su WH, Yu KJ, Cheng YJ, Tsang NM, Hsu MM, Chang KP, Chen IH, Chen TI, Yang CS, Golstein AM, Chen CJ, Chang YS, Hildesheim A (2012b) Evaluation of human leukocyte antigen-A (HLA-A), other non-HLA markers on chromosome 6p21 and risk of nasopharyngeal carcinoma. PLoS ONE 7:e427677
33. Huang YT, Jen CL, Yang HI, Lee MH, Lu SN, Iloeje UH, Chen CJ (2011) REVEAL-HBV/HCV Study Group. Lifetime risk and gender difference of hepatocellular carcinoma among patients affected with chronic hepatitis B and C. J Clin Oncol 29:3643-36500
34. IARC (2009)(International Agency for Research on Cancer) A review of human carcinogens. Part B: biological agent.
35. Lyon, IARC Lee MH, Yang HI, Lu SN, Jen CL, Yeh SH, Liu CJ, Chen PJ, You SL, Wang LY, Chen WJ, Chen CJ (2010) Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: long-term predictors from a community-based cohort study. J Clin Oncol 28:4587-45933
36. Lee MH, Yang HI, Liu J, Batrla-Utermann R, Jen CL, Iloeje UH, Jun J, Lu SN, You SL, Wang LY, Chen CJ (2013) For the R.E.V.E.A.L.-HBV Study Group. Models predicting long-term risk of liver cirrhosis and hepatocellular carcinoma in chronic hepatitis B patients: risk scores integrating characteristics of host and hepatitis B virus. Hepatology (in press)
37. Liaw YF, Sung JJ, Chow WC, Farrell G, Lee CZ, Yuen H, Tanwandee T, Tao QM, Shue K, Keene ON, Dixon JS, Gray DF, Sabbat J (2004) Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med 351:1521-311
38. Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL (2005) Global epidemiology of HTLV-1 infection and associated diseases. Oncogene 24:6058-60688
39. Sun CA, Wu DM, Lin CC, Lu SN, You SL, Wang LY, Wu MH, Chen CJ (2003) Incidence and co-factors of hepatitis C virus-related hepatocellular carcinoma: a prospective study of 12,0088 men in Taiwan. Am J Epidemiol 157:674-6822
40. Wang LY, Hatch M, Chen CJ, Levin B, You SL, Lu SN, Wu MH, Wu WP, Wang LW, Wang Q, Huang GT, Yang PM, Lee HS, Santella RM (1996) Aflatoxin exposure and the risk of hepatocellular carcinoma in Taiwan. Int J Cancer 67:620-6255
41. Wang LY, You SL, Lu SN, Ho HC, Wu MH, Sun CA, Yang HI, Chen CJ (2003) Risk of hepatocellular carcinoma and habits of alcohol drinking, betel quid chewing, and cigarette smoking: a cohort of 2416 HBsAg-seropositive and 9421 HBsAg-seronegative male residents in Taiwan. Cancer Cause Control 14:241-2500
42. Ward MH, Pan WH, Cheng YJ, Li FH, Brinton LA, Chen CJ, Hsu MM, Chen IH, Levine PH, Yang CS, Hildesheim A (2000) Dietary exposure to nitrite and nitrosamines and risk of nasopharyngeal cancer in Taiwan. Int J Cancer 2000(86):603-6099
43. GLOBOCAN http://globocan.iarc.fr/factsheets/populations/factsheet.aspuno= 9000
44. Yang HI, Lu SN, You SL, Sun CA, Wang LY, Hsiao K, Chen PJ, Chen DS, Liaw YF, Chen CJ (2002) Hepatitis B e antigen and the risk of hepatocellular carcinoma. New Engl J Med 347:168-1744
45. Yang HI, Yeh SH, Chen PJ, Iloeje UH, Jen CL, Wang LY, Lu SN, You SL, Chen DS, Liaw YF, Chen CJ, REVEAL-HBV Group (2008) Association between Hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. J Natl Cancer Inst, 100: 1134-11433
46. Yang HI, Sherman M, Su J, Chen PJ, Liaw YF, Iloeje UH, Chen CJ (2010) Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection. J Clin Oncol 28:2437-24444
47. Yang HI, Yuen MF, Chan HL, Han KH, Chen PJ, Kim DY, Ahn SH, Chen CJ, Wong VW, Seto WK (2011) Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score. Lancet Oncol 12:568-5744
48. Yu MW, Chen CJ (1993) Elevated serum testosterone levels and risk of hepatocellular carcinoma. Cancer Res 53:790-7944
49. Yu MW, Gladek-Yarborough A, Chiamprasert S, Santella RM, Liaw YF, Chen CJ (1995a) Cytochrome P-450 2E1 and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma. Gastroenterology 109:1266-12733
50. Yu MW, Hsieh HH, Pan WH, Yang CS, Chen CJ (1995b) Vegetable consumption, serum retinol level and risk of hepatocellular carcinoma. Cancer Res 55:1301-13055
51. Yu MW, Chiu YH, Chiang YC, Chen CH, Lee TH, Santella RM, Chen HD, Liaw YF, Chen CJ (1999a) Plasma carotenoids, glutathione S-transferases M1 and T1 genetic polymorphisms, and risk of hepatocellular carcinoma: Independent and interactive effects. Am J Epidemiol 149:621-6299
52. Yu MW, Horng IS, Hsu KH, Chiang YC, Liaw YF, Chen CJ (1999b) Plasma selenium levels and risk of hepatocellular carcinoma among men with chronic hepatitis B virus infection. Am J Epidemiol 150:367-3744
53. Yu MW, Chang HC, Liaw YF, Lin SM, Lee SD, Chen PJ, Hsiao TJ, Lee PH, Chen CJ (2000a) Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives. J Natl Cancer Inst 92:1159-11644
54. Yu MW, Cheng SW, Lin MW, Yang SY, Liaw YF, Chang HC, Hsiao TJ, Lin SM, Lee SD, Chen PJ, Liu CJ, Chen CJ (2000b) Androgen-receptor CAG repeat, plasma testosterone levels, and risk of hepatitis B-related hepatocellular carcinoma. J Natl Cancer Inst 92:2023-20288
55. Yu MW, Yang SY, Pan IJ, Lin CL, Liu CJ, Liaw YF, Lin SM, Chen PJ, Lee SD, Chen CJ (2003) Polymorphisms in XRCC1 and glutathione S-transferase genes and hepatitis B-related hepatocellular carcinoma. J Natl Cancer Inst 95:1485-14888